An EDA tool that turns code into real hardware inside a chip—design, test, and run custom FPGA systems before anything is ...
The Federal Bureau of Investigation announced plans to buy nationwide access to a network of license plate readers, saying it will award contracts to one or more vendors that can offer “near real time ...
Context Engine, Autonomous Data Analytics, and Workflow Data Fabric give enterprises the live, governed data that autonomous AI needs to act Most enterprise AI fails not because the models are flawed, ...
When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real time, FDA Commissioner Marty Makary, MD, MPH, reached for an analogy from ...
WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...
The game of global influence has changed. China has undertaken a concerted effort over the last two decades to establish a web of interlocking influence structures, including economic power, media ...
Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ...
WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the agency to monitor clinical trial data in real time, a step the agency ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.
Keeping tabs on blood sugar throughout the day used to be the exclusive domain of people with diabetes. But in 2026, anyone can buy a user-friendly wearable device that provides minute-by-minute ...
Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results